Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ScRNAseq of Sox17-Erg and Etv2 iECs at Day 3 and Day 7

ABSTRACT: scRNAseq of Sox17-Erg and Etv2 iECs at Day 3 and Day 7

PROVIDER: PRJNA903809 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR22355479_1.fastq.gz	Fastqsanger.gz
	SRR22355479_2.fastq.gz	Fastqsanger.gz
	SRR22355480_1.fastq.gz	Fastqsanger.gz
	SRR22355480_2.fastq.gz	Fastqsanger.gz
	SRR22355481_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 16

Similar Datasets

scRNAseq of Sox17-Erg and Etv2 iECs at Day 3 and Day 7

Project description:Evaluation of direct reprogramming heterogeneity of neonatal murine cardiac fibroblasts into iECs at Day 3 and Day 7

2024-03-22 | GSE218417 | GEO

Bulk RNAseq of Day 3, Day 7, and 4 week iECs

Project description:Sox17-Erg direct reprogramming converts neonatal murine cardiac fibroblasts into induced endothelial cells. This data evaluates the conversion over time of the Sox17-Erg iECs compared to control condition.

2024-03-22 | GSE218414 | GEO

Sox17-Erg cardiac iEC reprogramming

Project description:Bioinformatic Analyses of Sox17-Erg reprogramming

2024-03-21 | GSE218418 | GEO

Sox17-Erg cardiac iEC reprogramming

Project description:Sox17-Erg cardiac iEC reprogramming

| PRJNA903803 | ENA

scRNAseq of adult iECs

Project description:Evaluation of Sox17-Erg adult cardiac fibroblast reprogramming at Day 3, Day 7, 2 weeks, and 4 weeks

2024-03-26 | GSE249371 | GEO

SOX17/ETV2 Improves the Direct Reprogramming of Adult Fibroblasts to Endothelial Cells

Project description:In this study, we directly reprogram adult human dermal fibroblasts (NHDF) into reprogrammed ECs (rECs) by overexpressing SOX17 in conjunction with ETV2. The rECs are capable of emulating in vitro and in vivo EC functions better than cells reprogrammed with ETV2 alone, such as improved reprogramming efficiency, enriched in more EC genes, and form large blood vessels carrying blood from the host, and most importantly, start to express eNOS in vivo. From these results, we present an improved method to reprogram adult fibroblasts into functional ECs and posit ideas for the future that could potentially further improve the reprogramming process.

2024-02-20 | GSE256181 | GEO

H3K27ac CUT&Tag iEC reprogramming

Project description:H3K27ac CUT&Tag analysis of Sox17-Erg and Etv2 reprogramming of cardiac fibroblasts into endothelial cells

2024-03-22 | GSE218415 | GEO

Bulk RNAseq of Day 3, Day 7, and 4 week iECs

Project description:Bulk RNAseq of Day 3, Day 7, and 4 week iECs

| PRJNA903807 | ENA

cAMP/EPAC signaling enables ETV2 to induce endothelial cells with high angiogenesis potential [RNA-seq]

Project description:Although the generation of ETV2-induced endothelial cells (iECs) from human fibroblasts serves as a novel therapeutic strategy in regenerative medicine, the process is inefficient, resulting in incomplete iEC angiogenesis. Therefore, we employed ChIP-sequencing and identified molecular mechanisms underlying ETV2-mediated endothelial transdifferentiation to efficiently produce iECs retaining appropriate functionality in long-term culture. We revealed that the majority of ETV2 targets in human fibroblasts are related to vasculature development and signaling transduction pathways including Rap1 signaling. From a screening of signaling pathway modulators, we confirmed that forskolin facilitated efficient and rapid iEC reprogramming via activation of cAMP/EPAC/RAP1 axis. The iECs obtained via cAMP signaling activation showed superior angiogenesis in vivo as well as in vitro. Moreover, these cells could form aligned endothelium along the vascular lumen ex vivo when seeded into decellularized liver scaffold. Overall, our study provided evidence that cAMP/EPAC/RAP1 axis is required for the efficient generation of iECs with angiogenesis potential.

2019-11-09 | GSE123907 | GEO

cAMP/EPAC signaling enables ETV2 to induce endothelial cells with high angiogenesis potential [ChIP-seq]

2019-11-09 | GSE123906 | GEO